Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Ruxolitinib Oral Tablet [Jakafi]
Lenalidomide
+1 more
Locations
13
United States
Global Oncology, Inc.
Alhambra, California, United States
Comprehensive Blood and Cancer Center
Bakersfield, California, United States
California Cancer Associates for Research & Excellence (cCARE)
Encinitas, California, United States
Compassionate Care Research Group, Inc.
Fountain Valley, California, United States
Robert A. Moss, M.D., F.A.C.P., Inc.
Fountain Valley, California, United States
Pacific Cancer Care
Monterey, California, United States
Start Date
February 1, 2017
Primary Completion Date
September 1, 2024
Completion Date
February 1, 2027
Last Updated
November 1, 2023
NCT06679101
NCT05969860
NCT06870760
NCT06057402
NCT06383143
NCT06285318
Lead Sponsor
Oncotherapeutics
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions